Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

583.80INR
20 Jul 2018
Change (% chg)

Rs15.95 (+2.81%)
Prev Close
Rs567.85
Open
Rs568.00
Day's High
Rs589.45
Day's Low
Rs566.75
Volume
1,676,065
Avg. Vol
2,256,505
52-wk High
Rs809.45
52-wk Low
Rs527.00

Select another date:

Mon, Jul 16 2018

BUZZ-Apotex deal to help India's Aurobindo Pharma deepen EU presence - Citi

** Citi says Aurobindo Pharma Ltd's 74 mln euros ($86.6 mln) deal to buy some European businesses of Canadian firm Apotex International Ltd is part of inorganic strategy

BUZZ-India's Aurobindo Pharma slips on Q4 miss

** Aurobindo Pharma Ltd plunges as much as 6.2 pct to 567.95 rupees, its lowest in a week

Aurobindo Pharma fourth-quarter profit misses estimates

India's Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts' estimates.

India's Aurobindo Pharma Q4 profit misses estimates

May 28 India's Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts' estimates.

MEDIA-India's Aurobindo Pharma eyes Mallinckrodt Opioids again - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

BRIEF-Aurobindo Pharma Says U.S. FDA Issued Form 483 With 9 Observations for Co's Unit

* AUROBINDO PHARMA LTD CLARIFIES ON NEWS ITEM ON CO'S UNIT 4 GETTING 9 OBSERVATIONS AFTER U.S. FDA INSPECTION

BUZZ-India's Aurobindo Pharma falls; USFDA cites quality issues at unit - report

** Drugmaker Aurobindo Pharma Ltd falls as much as 5.5 pct to 590 rupees, its lowest since Feb 23

MEDIA-India's Aurobindo Pharma eyes European business of Apotex - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

BRIEF-Aurobindo Pharma Says Approved Dividend Of 1 Rupee Per Share

* SAYS APPROVED SECOND INTERIM DIVIDEND OF 1 RUPEE PER SHARE Source text for Eikon: Further company coverage:

Aurobindo Pharma Q3 profit up about 3 pct, misses estimates

Feb 7 Aurobindo Pharma Ltd, India's third largest drugmaker by revenue, posted an about 3 percent rise in quarterly profit on Wednesday, but missed analysts' estimates.

Select another date: